Abstract
The aim of this study was to investigate the nigrostriatal dopaminergic function in patients with corticobasal degeneration (CBD) using [2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3.2.1]oct-2-yl]methyl](2-mercaptoethyl)amino]ethyl]amino]ethanethiolato(3-)-N2,N2′,S2,S2′]oxo-[1R-(exo-exo)]-[99mTc]technetium ([99mTc]TRODAT-1) brain single-photon emission tomography (SPET).
| Original language | English |
|---|---|
| Pages (from-to) | 339-345 |
| Number of pages | 7 |
| Journal | Nuclear Medicine Communications |
| Volume | 25 |
| Issue number | 4 |
| DOIs | |
| State | Published - 04 2004 |
| Externally published | Yes |
Keywords
- Corticobasal degeneration
- Dopamine transporter
- Early stage
- Idiopathic Parkinson's disease
- [Tc]TRODAT-1